SCHEMBL4278583

SCHEMBL4278583

CCOC(=O)/C=C/c1ccccc1OCC(C)C

nearest known ligand 0.49

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 5/20 0.48
HPGD P15428 5/20 0.48
KDM4E B2RXH2 4/20 0.48
SMN1; SMN2 Q16637 3/20 0.48
MAPT P10636 4/20 0.48
LMNA P02545 3/20 0.48
ATM Q13315 1/20 0.48
RAB9A P51151 2/20 0.46
NPC1 O15118 1/20 0.46
S1PR4 O95977 1/20 0.46
ITGA4 P13612 1/20 0.46
S1PR1 P21453 1/20 0.46
MAPK1 P28482 1/20 0.46
NPSR1 Q6W5P4 1/20 0.46
TLR9 Q9NR96 1/20 0.46
FDPS P14324 1/20 0.45
NFE2L2 Q16236 2/20 0.44
CA12 O43570 1/20 0.44
CA1 P00915 1/20 0.44
CA2 P00918 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4278586 1.00 ALDH1A1 (0.48) ALDH1A1HPGDKDM4ESMN1; SMN2MAPT
SCHEMBL4289061 0.88 ALDH1A1 (0.50) ALDH1A1HPGDKDM4ESMN1; SMN2MAPT
SCHEMBL4289072 0.88 ALDH1A1 (0.50) ALDH1A1HPGDKDM4ESMN1; SMN2MAPT
SCHEMBL3536947 0.87 SMN1; SMN2 (0.60) ALDH1A1HPGDKDM4ESMN1; SMN2MAPT
SCHEMBL3536949 0.87 SMN1; SMN2 (0.60) ALDH1A1HPGDKDM4ESMN1; SMN2MAPT
SCHEMBL7221481 0.85 ALDH1A1 (0.54) ALDH1A1HPGDKDM4ESMN1; SMN2MAPT
SCHEMBL7221477 0.85 ALDH1A1 (0.54) ALDH1A1HPGDKDM4ESMN1; SMN2MAPT
SCHEMBL19244465 0.83 AR (0.51) ALDH1A1HPGDKDM4ESMN1; SMN2MAPT
SCHEMBL28155056 0.83 ALDH1A1 (0.53) ALDH1A1HPGDKDM4ESMN1; SMN2MAPT
SCHEMBL19244427 0.83 ALDH1A1 (0.53) ALDH1A1HPGDKDM4ESMN1; SMN2MAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20090118169-A1 NOVEL COMPOUNDS AND PHARMACEUTICAL USE THEREOF TOYAMA CHEMICAL CO., LTD. (JP) 2009-05-07 US disclosed
US-7314888-B1 Compounds and medicinal use thereof TOYAMA CHEMICAL CO., LTD. (JP) 2008-01-01 US disclosed
EP-1127869-A1 NOVEL COMPOUNDS AND MEDICINAL USE THEREOF TOYAMA CHEMICAL CO., LTD. (JP) 2001-08-29 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090118169-A1 NOVEL COMPOUNDS AND PHARMACEUTICAL USE THEREOF SP1, AP1G1, AP1M1 ALDH1A1 2031/4885HPGD 2556/4885KDM4E 3794/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.